Skip to content

भाषा बदलें: हिंदी में

mTatva Health-PIE

Search for:

Home
Health Articles
Disease Facts
Drug Facts – Brands
Drug Facts – Generics

Category: HEDGEHOG PATHWAY INHIBITORS

Drug Classification

VISMODEGIB

September 13, 2018 mTatva Health

VISMODEGIB is a Schedule H drug.

HEDGEHOG PATHWAY INHIBITORSmedicine for basal cell carcinoma

Like us

Top Posts & Pages

REXIDIN-M FORTE GEL
GLIFID M 80MG TAB
REVLAMER 400MG TAB
MEFNUM SPAS 10MG/250MG TAB
World No Tobacco Day: Tobacco a Threat to Development
HUMSTARD 30/70 40IU INJ
ULTRACID M 400MG/20MG SUSP
BOOSTRIX INJ
Thalassemia: Meaning, Diagnosis and Overview
VELTAM 0.2MG TAB

Recent Posts

Games changers of Healthcare – AI and IoMT
ULTRAMED 325MG/37.5MG TAB
ULTRAM 325MG/37.5MG TAB
ULTRAGIN 500MG TAB
ULTRACET SEMI 162.5MG/18.75MG TAB
ULTRACET 325MG/37.5MG TAB
ULTRABEST 37.5MG/325MG TAB
ULTRA PLUS H 162.5MG/18.75MG TAB
ULTRA PLUS 325MG/37.5MG TAB
ULTIMIDE 750MG TAB
ULTIFIX PLUS TAB
ULTIFIX LB TAB
ULTIFIX CV 250MG/125MG TAB
ULTIFIX 50MG TAB DT
ULTIFIX 50MG DRY SYP
ULTIFIX 200MG TAB DT
ULTIFIX 100MG TAB DT
ULTICAN 150MG TAB
ULEEV 250MG TAB
UCO 150MG TAB

1 2 3 100MG TAB
1 2 3 25MG TAB
1 2 3 50MG TAB
1 AL 10MG TAB
1 AL 2.5MG SYP

Home
Health Articles
Disease Facts
Drug Facts – Brands
Drug Facts – Generics

Copyright Since 2013. All rights reserved @mTatva

Proudly powered by WordPress | Education Hub by WEN Themes

X

Your Personal Doctor on Mobile
Get 1000+ diseases comprehensive information on your mobile

Download App Now